...
首页> 外文期刊>Drug discovery today >Selecting protein tyrosine phosphatases as drug targets.
【24h】

Selecting protein tyrosine phosphatases as drug targets.

机译:选择蛋白质酪氨酸磷酸酶作为药物靶标。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Protein tyrosine phosphatases (PTPs) have emerged as a new and promising class of signaling targets, since the discovery of PTP1B as a major drug target for diabetes and obesity. Blocking individual PTPs results in the activation of specific tyrosine phosphorylation events, but matching PTPs with such pathways and therapeutic indications is a complex undertaking. The history of PTP1B shows that its unusual knockout phenotype and observations with generic and antisense inhibitors in vivo, but not its classical molecular biology, triggered the rapid development of inhibitors that are today being developed for the clinic.
机译:自从发现PTP1B作为糖尿病和肥胖症的主要药物靶标以来,蛋白质酪氨酸磷酸酶(PTPs)就已经成为一种新型的有希望的信号转导靶标。阻断单个PTP会导致特定酪氨酸磷酸化事件的激活,但是将PTP与此类途径和治疗适应症相匹配是一项复杂的工作。 PTP1B的历史表明,其不寻常的基因敲除表型以及在体内使用普通和反义抑制剂的观察结果,而不是其经典的分子生物学,触发了如今为临床开发的抑制剂的快速发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号